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Summary:  This paper gives an overview of recent European Union projects on 
the assessment of driver impairment.  Whereas previous research has focused on 
vehicle technology (DREAM, DETER) or Human Machine Interfacing (SAVE), 
more recent efforts have been based on methods to detect the presence of 
substances (ROSITA) or the level of impaired performance at the roadside 
(CERTIFIED, IMMORTAL).  This paper will summarize the objectives and main 
conclusions of the most recent projects. 
 
THE EUROPEAN SCENE 
 
Since the beginning of auto mobility the number of accidents shows a steady and seemingly 
uncontrolled increase, causing as much as up to 1,700,000 injured and 55,000 deaths in Europe 
each year in the nineties, amounting to over 150 million KEuro each year. Thus, traffic accidents 
are amongst the three most common causes of death within Europe. This has inspired the European 
Commission to finance research and development programs to diminish the accident rates. 
 
Smiley and Brookhuis (1987) concluded that some 90% of all traffic accidents can be attributed to 
human failure in general. It is estimated that at least 30% of all serious car accidents must be 
attributed to problems concerning driver state, by factors such as alcohol or drug use and / or abuse, 
drowsiness or fatigue, prolonged periods of inattention and health problems (e.g. heart attack, 
epileptic seizure, fainting). The costs of this type of accidents for society are considerable, and 
efforts must be made to significantly reduce this accident type.  
 
The prevention or reduction of traffic accidents requires countermeasures to prevent or mitigate 
driver behaviours that contribute to accidents. Brookhuis & Brown (1992) argue that an 
ergonomic approach to behavioural change via engineering measures, in the form of ITS driving 
aids and detection methods, should be adopted in order to improve road safety, transport 
efficiency and environmental quality. 
 
The Commission of the European Union launched ambitious so-called framework programmes 
in the field of road transport informatics and telecommunications (ITS) to improve the mentioned 
conditions with respect to road safety, transport efficiency and environmental quality 
(www.cordis.lu). These programmes seek to create favourable conditions for the development of 
an integrated road transport environment through collaborative efforts in information technology 
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and telecommunications applied to road transport. Certain projects within these programmes aim 
to detect inadequate vehicle control under conditions where the driver's cognitive, perceptual and 
motor abilities may become impaired (i.e. accident risk is increased) as a consequence of 
psychoactive substances.  
INTERVENTIONS TO DRIVER IMPAIRMENT 
 
Legislation and enforcement of driver impairment based on detection is a common intervention 
method for traffic safety. The common aspect of each of these approaches is the need for a 
reliable and valid metric to quantify impairment and the establishment of a criterion to determine 
the level of impairment that can be justified to be ‘unsafe’. Whereas the provision of a suitable 
metric is subject to usual psychometric considerations for performance testing, the determination 
of a criterion level is most problematic and can be elusive. While a variety of methodologies 
exist to derive a criterion (see also Brookhuis et al., in press), the effort required may be 
extensive and the underlying assumptions may be dubious. 
 
The first stage of this process is to relate the impairment metric to a risk function.  For example, 
this may involve relating the range of dose, or psychomotor impairment, or driving performance 
to corresponding levels of risk.  Risk itself can be quantified in two ways, either directly or 
indirectly: 
 
• Risk – Directly compute the risk curve in terms of the probability of being in an accident 
with a specified level of detected substance or condition (relative to non-accident cases). 
The effort required for this epidemiological approach is intensive although an appropriate 
case-control methodology can produce valuable and valid results (e.g., Grand Rapids 
study). 
• Surrogate – Indirectly relate performance level to an approximation of an accident or 
increase in accident probability (e.g., correlate lane position variability with a proxy for 
accident liability such as exceeding lane boundaries). The validity of the predictive model 
is dependent on the strength of the relationship of the proxy measure to the actual 
accident risk and has limited application outside the initial value range of the 
performance measures. 
 
Once a risk (or surrogate) function can be estimated, a threshold value to demarcate unacceptable 
risk can be set.  There are several rationale for setting the threshold: 
 
• Precedence – Select threshold comparable to a level obtained with an existing reference 
level that is currently enforced such as BAC 0.08%. This assumes that the risk function 
and the form of impairment is similar to alcohol. 
• Reference – Select threshold comparable to a normative task such as tuning a radio which 
is common to the driving environment. This also assumes a similar risk function and form 
of impairment, but also assumes that the existing risk is ‘acceptable’. 
• Consensus – Concede threshold level from agreement amongst experts and authorities. 
This approach might derive a compromise level that satisfies pragmatics and politics, but 
is not consistent with scientific consideration of the underlying assumptions. 
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• Baseline – Rather than consider risk directly, this approach sets the threshold in terms of 
a percentile in the baseline metric.  For example, driver performance may be compared to 
own baseline performance without impairment with the threshold set to an extreme 
percentile (95th). At present it is impractical to obtain baselines date for all drivers, and it 
is not clear what between subject baseline population is appropriate.  Indeed, the 
threshold criterion is also not a standard.  
 
Once a threshold risk value has be determined, it can then be related back to the function which 
quantifies the impairment metric to determine the corresponding criterion level.  For example, if 
the risk level associated with BAC 0.08% is chosen as the threshold value, the criterion for 
fatigue could be the amount of steering variability which corresponds to that same risk threshold 
as derived by a function relating accident risk to fatigue level operationalized by the steering 
metric of impairment. 
 
The form of detection that may be proposed is specific to the type of impairment factor, the level 
of impairment metric used (e.g., dose, psychomotor, driver performance), and the type of 
legislation considered. Two proposed forms of detection of impairment from the (acute) driver 
state are in-vehicle monitoring and roadside testing. A third form of detection based on the 
evaluation of (chronic) driver fitness (i.e., aptitude and ability) is licensing assessment. The 
SAVE project (System for effective Assessment of the driver state and Vehicle control in 
Emergency situations) aims at in-vehicle detection of impaired driver performance, by 
psychoactive substances among others. Other projects aim at improving methods of roadside 
psychomotor impairment testing, such as CERTIFIED (Conception and Evaluation of Roadside 
Testing Instruments to Formalise Impairment Evidence in Drivers) or developing methods of 
substance detection (dose) with roadside drug screening as was done in ROSITA (ROadSIde 
Testing Assessment). 
 
The SAVE Project (http://www.iao.fhg.de/projects/SAVE/) 
 
The objective of the SAVE project was to develop a demonstration prototype of an actual 
product (in-vehicle SAVE monitoring unit) that will in real time detect impaired driver state and 
undertake emergency handling, prior and during the emergency situation occurrence. This will be 
realised by instant detection of driver impairment, whereupon firstly the driver is warned, then if 
necessary drivers in the immediate environment and ultimately an emergency centre, hence 
shifting the car operation to an automatic driving mode, in order to ensure safe control of the 
vehicle. 
 
Central to this approach was the development of an in-vehicle driver impairment monitor, the 
Integrated Monitoring Unit (IMU), introduced and found feasible in earlier EU projects 
(DREAM and DETER, see De Waard & Brookhuis 1991). It concerns the development of a 
prototype system, capable of detecting driver impairment from vehicle sensors alone. The IMU 
itself is divided into three functional units, the vehicle sensors that collect instantaneous driving 
data, an advanced diagnosis or classification subsystem that analyses and interprets this data and 
the storage / retrieval device which is used as a template of normal driving behaviour. The 
diagnosis or classification subsystem consists of a series of processing algorithms in sequence 
centred on a Neural Network. The sequence consists of pre-processing by Independent 
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Component Analysis (a for this purpose more suitable form of Principal Component Analysis), 
processing by an Artificial Neural Net, after which final diagnosis is performed with the aid of 
Fuzzy Logic. 
The classification or diagnosis by the system is either normal or abnormal driving, for which the 
critical values of driver actions are of two types, absolute and relative. Absolute critical values 
refer to levels of measured driver actions that would imply a direct, acute danger of accident 
involvement to the vehicle and driver. For example, driving at 0.1 second time-headway to a lead 
car whereas a minimum human reaction time in laboratory circumstances is around 0.2 seconds. 
Relative critical values are individual and refer to decrements in driver actions that indicate 
psychological impairment, without direct relationship to likelihood of accident involvement. For 
a more extended review on critical values, see Brookhuis et al. (in press). 
 
The CERTIFIED Project (http://www.psyc.leeds.ac.uk/certified/) 
 
The CERTIFIED Project aimed to contribute to the existing knowledge base concerning drugs 
and traffic safety, supporting the development of methods for roadside testing applicable to 
driver impairment from licit and illicit drugs. The project had the following objectives: 
 
• Review impairment and accident risk evidence for drugs and medicines; 
• Review existing methods of impairment testing and propose new methods (including 
pilot studies of testing efficacy); 
• Formulate verification methodology for testing methods based on user, legal and 
operational requirements; 
• Identify key issues relevant to policy formulation. 
 
A preliminary safety prioritisation of drug groups on the basis of a newly developed (standard) 
metric is: 
 
• High Priority = Alcohol, Benzodiazepines 
• Medium Priority = Amphetamines, Opiates, Cocaine, Cannabis 
• Low Priority = Methadone, Antihistamines, Antidepressants 
 
To meet the established requirements of a new, suitable roadside test, it is likely that it comprises 
several types of measurement in a standardised format. Account should be taken of both within- 
and between-subject variances of drivers, and an adequate normative database needs to be 
established. The test should maximise the chances of detection while keeping the number of false 
positives to a minimum. 
 
The ROSITA Project (http://www.rosita.org/) 
 
The aim of the ROSITA project was to identify the requirements for roadside testing equipment 
based on the detection of substances and to make a comparative assessment of equipment for this 
purpose. This assessment considered the reliability, validity, practicality, and cost-benefit of 
these devices for roadside detection of impairment substances. Thus, ROSITA can be considered 
the sister project to CERTIFIED which reviewed requirements for roadside assessment of 
behaviors indicative of impairment. The following main conclusions were offered: 




• There is a need for roadside testing to support legislation regarding impairment and drug 
use. 
• The perceived need is so great that some enforcement officers would rather use an 
imperfect device than have no device at all. 
• Roadside testing should be used to support police action on-site, but legal sanctions 
should be corroborated with reference methods based on (i) confirmation analyses with 
blood samples, or (ii) identification of behavioral impairment. 
• Whereas the majority of users prefer saliva as the fluid for testing, this method can be 
problematic (e.g., some drugs may produce a dry mouth) and requires that the device is 
highly sensitive.  Moreover, whereas the correspondence between saliva and confirmation 
analyses with blood may be acceptable for some drugs (e.g., Cannabinoids, Opiates, 
Cocaine, Amphetamines), tests for other common drugs in the driving context are less 
sensitive with saliva sampling.  Indeed, current methods for testing saliva samples are 
considered to be ‘too complex’. 
• There is not sufficient data to propose criterion levels for detected substances in terms of 
cut-offs for pass/fail determination. 
• A EU Technical Review Committee and the adoption of a single set of regulations for 
impaired driving would benefit advancement of roadside testing. 
 
The Next Steps – AWAKE and IMMORTAL1
 
 
As part of the key action Sustainable Mobility and Intermodality in the European Fifth 
Framework Program, the Commission of the European Union has funded consortia to conduct 
research in support of transportation policy on driver physical fitness and physical state. These 
projects are both a sequel of the above mentioned projects. The first one is called System for 
effective Assessment of driver vigilance and Warning According to traffic risK Estimation 
(AWAKE) and the second one is entitled Impaired Motorists, Methods Of Roadside Testing and 
Assessment for Licensing (IMMORTAL), comprising a total of 10 partners from 7 different 
European countries. They are planned to be 3 year projects scheduled to be funded from 2001. 
 
The objectives of AWAKE are to (i) develop a hypovigilance diagnosis module that will detect 
and diagnose driver hypovigilance in real time, (ii) develop a modular, on-time driver warning 
system and (iii) develop a traffic risk estimation module. All these modules are to be integrated 
in a passenger car and a heavy goods vehicle demonstrator, and tested. 
 
The main research areas for IMMORTAL are (i) ageing, mental illness and medical disease; and 
(ii) alcohol, licit and illicit drugs. This research aims at contributing to policy support activities 
including cost-benefit analyses of intervention methods and user workshops with policy makers 
to review the research conclusions in the European transportation context. 
 
                                                 
1 Information about AWAKE can be derived from K.A.Brookhuis or the co-ordinator Angelos Bekiaris 
(trnspcon@compulink.gr). Information from IMMORTAL can be obtained from N. Ward as the Technical Advisor for 
this project (nicw@hfrl.umn.edu) or from Bob Hockey who is the project co-coordinator 
(bobh@psychology.leeds.ac.uk). 
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The primary objective of this research is to provide evidence to propose intervention methods for 
driver impairment, and support the future development of European policy governing driver 
impairment legislation. The forms of intervention method considered will be licensing 
assessment for chronic impairment of driver fitness, and roadside impairment assessment for 
acute impairment of driver state: 
 
At present, there is insufficient information to support policy and the development of valid and 
standard protocols to evaluate driver impairment. On this basis, both AWAKE and IMMORTAL 
have a number of specific evidentiary objectives to support the stated aim: 
 
• Investigate the influence of chronic and acute impairment factors on driving performance 
and accident risk; 
• Recommend criteria (‘tolerance levels’) for high risk categories of impairment; 





There have been a number of European projects dedicated to driver impairment. The trend has 
been for a change in research from early attempts to make online assessment of driver 
performance with in-vehicle systems, to the assessment of driver impairment either by roadside 
testing or licensing assessment. 
 
Whereas recent projects have evaluated methods to detect impairment substances in drivers, 
future research will examine methods to test impairment of driver functions. These methods 
consider ‘unsafe’ impairment levels regardless of the source. Accordingly, such methods may be 
more generic and directly related to the intent of enforcement law that stipulates that driving 
while impaired is illegal without specifying the source of impairment. However, the key obstacle 
to all such endeavours of this type is to devise a method by which a valid criterion for ‘unsafe’ 
impairment can be determined. 
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